Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Avanti Communications Group Plc 21 December 2009 ? Date: 21 December 2009 On behalf of: Avanti Communications Group plc ("Avanti", "the Group" or "the Company") Embargoed until:0700hrs...
NEW YORK, Aug. 29 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Merrill Lynch's 12% Callable STRIDES Linked to Apple, Inc. Priced at $25.00 per unit with an...
IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company specializing in anti-allergy medications, announced today...
The previously announced one-for-four reverse split by AVANIR Pharmaceuticals (AMEX:AVN) of its common stock has become effective, with post-split trading expected to begin under a new ticker...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that it has signed an exclusive agreement with a leading importer and distributor of pharmaceuticals in Japan to develop and market...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that Randall E. Kaye, M.D. has joined the company in the newly created role of Vice President of Medical Affairs. Dr. Kaye will focus on...
AVANIR Pharmaceuticals (AMEX: AVN) announced today that its Board of Directors has approved the implementation of a one-for-four reverse split of the company's common stock. The reverse split was...
AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2005, at 4:00 p.m. PT in San Francisco. AVANIR's President...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca) to evaluate the human safety of AZD2479...
AVANIR Pharmaceuticals (AMEX: AVN) announced today that its presentation at the Lazard Capital Markets Annual Life Sciences Conference in New York, NY, will be webcast live on November 30th, 2005...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Symbol | Preis | Vol. |
|---|---|---|
| AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 26,5099 (0,00%) | 0 |
| AAPXT Rex 2X Long Apple Daily Target ETF | US$ 30,16 (0,00%) | 0 |
| AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 26,42 (0,00%) | 0 |
| AAAUGoldman Sachs Physical Gold ETF Shares | US$ 26,33 (0,00%) | 0 |
| AAAAlternative Access First Priority CLO Bond ETF | US$ 25,125 (0,00%) | 0 |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
